F

FuturHealth

Telehealth weight management with personalized prescriptions

Overview

FuturHealth provides telehealth-based weight management by combining prescription medications (including GLP-1 therapies) with personalized diet plans and coaching. Clients begin with an online assessment, receive a tailored prescription after doctor consultations, and continue with subscription-based support that includes meal plans and home-delivered medication. It differentiates itself by prioritizing individual needs and integrating medical treatment with customized diet and coaching, all accessible nationwide through a subscription model. Its goal is to make personalized, comprehensive weight-management care easy to access for millions of US users.

Funded Recently

Work here?Claim your company

About FuturHealth

Simplify's Rating
Why FuturHealth is rated
D+
Rated C on Competitive Edge
Rated D+ on Growth Potential
Rated D- on Differentiation

Industries

Data & AnalyticsConsumer SoftwareHealthcare

Company Size

11-50

Company Stage

Bankrupt

Total Funding

N/A

Headquarters

San Diego, CA

Founded

2024

Get referred to FuturHealth

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • FuturHealth says 400,000 members validate demand for its subscription model.
  • Interim approval lets FuturHealth draw $1.5 million from its $5 million DIP facility.
  • Management has marketed to 135 parties, creating near-term acquisition interest before December 15, 2026.

What critics are saying

  • November 1, 2026 Chapter 11 filing makes survival depend on a court-supervised sale.
  • The Goglia Nutrition lawsuit blocked financing, forcing a bankruptcy filing after August 20, 2026.
  • Losing GLP-1 access or the sale process would likely kill FuturHealth's standalone business.

What makes FuturHealth unique

  • FuturHealth bundles prescribing, nutrition coaching, and home delivery into one weight-loss workflow.
  • April 2026 Foundayo launch made FuturHealth early to offer oral GLP-1 access.
  • Apple Fitness+ and Affirm integrations deepen retention and reduce payment friction for subscribers.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

N/A

N/A

Industry Average

Funded Over

1 Rounds

Bankruptcy funding comparison data is currently unavailable. We're working to provide this information soon!
Bankruptcy Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Remote Work Options
  • Unlimited Paid Time Off

Growth & Insights and Company News

6 month growth

-8%

1 year growth

0%

2 year growth

0%
Law360
Nov 3rd, 2026
FuturHealth gets interim approval to tap $1.5M of $5M Chapter 11 financing

FuturHealth, a telehealth platform focused on weight loss, can access $1.5 million of a $5 million debtor-in-possession loan. A Delaware bankruptcy judge granted interim approval of the financing on Tuesday. The company is in Chapter 11 bankruptcy proceedings.

PR Newswire
Apr 28th, 2026
FuturHealth launches Eli Lilly's oral GLP-1 pill Foundayo, removing injection barrier for 400K members

FuturHealth, a clinically-guided health platform, has announced it will offer orforglipron, Eli Lilly's oral GLP-1 receptor agonist marketed as Foundayo, through its nationwide service. The once-daily pill will be prescribed by affiliated clinical providers to eligible members and delivered via licensed pharmacy. Clinical trials showed patients with obesity lost an average of 12% of their body weight (approximately 27 pounds) over 72 weeks at the highest dose, alongside improvements in blood sugar control. The oral medication requires no food or water timing restrictions. FuturHealth's programme starts at $198 per month and combines medication access with personalised guidance on nutrition, movement and lifestyle. The company has served 400,000 people. The addition reflects growing demand for non-injectable GLP-1 alternatives, addressing needle-related barriers to treatment.

PR Newswire
Jan 26th, 2026
FuturHealth adds FDA-approved Wegovy pill to $198/month weight-loss programme with 17% results

FuturHealth, a personalized health and weight-loss platform, has expanded its care options to include the Wegovy pill, the first FDA-approved oral GLP-1 medication. The company's $198 monthly programme combines the prescription with medical support, Apple Fitness+ access, and optional customised meal plans. Founded in San Diego, FuturHealth has supported hundreds of thousands of members through its integrated approach. The addition of oral medication provides more flexibility for patients, with clinical providers evaluating each case individually for eligibility. Members can transition from injectable to oral therapy based on their clinical profile. According to FuturHealth's obesity specialist, the Wegovy pill has demonstrated average weight loss of approximately 17% when combined with lifestyle changes. The company positions itself as offering the most affordable FDA-approved GLP-1 option available.

The Mac Observer
Aug 11th, 2025
Apple Fitness+ Now Available Free to All FuturHealth Subscribers

Apple Fitness+ is expanding through a new partnership with FuturHealth, a subscription-based weight-loss service.

HIT Consultant
Mar 25th, 2025
Affirm + Futurhealth Partner To Make Glp-1 Medications More Accessible With Flexible Payment Options

What You Should Know: – FuturHealth, a provider of personalized weight-loss solutions partners with Affirm, the payment network that empowers consumers and helps merchants drive growth. – The collaboration will enable FuturHealth customers to use Affirm’s flexible, transparent pay-over-time options to purchase medications and wellness solutions.Flexible, Transparent Way to Pay Over Time for GLP-1 Medications and Wellness SolutionsNow, FuturHealth customers who are approved can finance the purchase of various weight-loss medications, including branded GLP-1 options such as Wegovy and Ozempic, as well as personalized meal plans, consultations, and lab services.These medications and wellness solutions have proven effective in managing weight and related health conditions but often come with a significant cost, sometimes exceeding $1000 per month. By integrating Affirm, FuturHealth aims to provide a more accessible and responsible way for customers to afford these important treatments and services.How it WorksApplying for Affirm is straightforward. During checkout on FuturHealth’s website, customers can select Affirm as their preferred payment method. They will then undergo a quick eligibility check. If approved, customers can choose from customized biweekly or monthly payment plans, with interest rates as low as 0% APR, and confirm their purchase.Affirm adheres to responsible lending practices, ensuring that customers are only approved for financing that Affirm believes they can repay. Furthermore, Affirm does not charge any late or hidden fees, providing customers with a transparent and predictable payment experience.AvailabilityCustomers can now visit FuturHealth’s website and select Affirm as a payment option when purchasing their weight-loss medications and services

Recently Posted Jobs

Sign up to get curated job recommendations

FuturHealth is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs